从2021年“罗马提议”看慢性阻塞性肺疾病急性加重定义及分级的变迁

doi:10.19983/j.issn.2096-8493.20210165

结核与肺部疾病杂志 ›› 2022, Vol. 3 ›› Issue (1): 1-3.doi: 10.19983/j.issn.2096-8493.20210165

• 述评 • 下一篇

从2021年“罗马提议”看慢性阻塞性肺疾病急性加重定义及分级的变迁

马义铭, 龙颖姣, 陈燕()

中南大学湘雅二医院呼吸与危重症医学科,长沙 410011

收稿日期:2021-12-31 出版日期:2022-02-20 发布日期:2022-02-24
通信作者: 陈燕 E-mail:chenyan99727@csu.edu.cn
基金资助:
国家自然科学基金(81873410);国家自然科学基金(81800043);国家自然科学基金(82070049);国家重点研发计划(2016YFC1304700);湖南省自然科学基金(2020JJ5818)

Received:2021-12-31 Online:2022-02-20 Published:2022-02-24

摘要/Abstract

中图分类号:

R563.3

马义铭, 龙颖姣, 陈燕. 从2021年“罗马提议”看慢性阻塞性肺疾病急性加重定义及分级的变迁[J]. 结核与肺部疾病杂志, 2022, 3(1): 1-3. doi: 10.19983/j.issn.2096-8493.20210165

图/表 1

参考文献 13

[1]	Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2022 reportreport[R/OL]. [2021-11-20]. https://goldcopd.org/2022-gold-reports-2/.
[2]	Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med, 2020, 41(3):421-438. doi: 10.1016/j.ccm.2020.06.007. doi: S0272-5231(20)30040-X pmid: 32800196
[3]	Celli BR, Fabbri LM, Aaron SD, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med, 2021, 204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP. doi: 10.1164/rccm.202108-1819PP URL
[4]	Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987, 106(2):196-204. doi: 10.7326/0003-4819-106-2-196. doi: 10.7326/0003-4819-106-2-196 pmid: 3492164
[5]	Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest, 2000, 117(5 Suppl 2):398S-401S. doi: 10.1378/chest.117.5_suppl_2.398s. doi: 10.1378/chest.117.5_suppl_2.398s URL
[6]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031. doi: 10.3760/cma.j.cn112147-20210109-00031
[7]	Celli BR. Dissecting COPD exacerbations: time to rethink our definition. Eur Respir J, 2017, 50(3):1701432. doi: 10.1183/13993003.01432-2017. doi: 10.1183/13993003.01432-2017 URL
[8]	Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax, 2012, 67(3):238-243. doi: 10.1136/thoraxjnl-2011-200768. doi: 10.1136/thoraxjnl-2011-200768 URL
[9]	Lopez-Campos JL, Agustí A. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. Lancet Respir Med, 2015, 3(9):729-734. doi: 10.1016/S2213-2600(15)00242-8. doi: 10.1016/S2213-2600(15)00242-8 URL
[10]	Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond), 1989, 76(3):277-282. doi: 10.1042/cs0760277. doi: 10.1042/cs0760277 URL
[11]	Nikolakopoulou S, Hillas G, Perrea D, et al. Serum angiopoietin-2 and CRP levels during COPD exacerbations. Copd, 2014, 11(1):46-51. doi: 10.3109/15412555.2013.829436. doi: 10.3109/15412555.2013.829436 pmid: 24102428
[12]	Carter JA, Burke HB. CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial. J Gen Intern Med, 2021, 36(7):2194-2196. doi: 10.1007/s11606-020-06053-0. doi: 10.1007/s11606-020-06053-0 URL
[13]	Prins HJ, Duijkers R, van der Valk P, et al. CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions. Eur Respir J, 2019, 53(5):1802014. doi: 10.1183/13993003.02014-2018. doi: 10.1183/13993003.02014-2018 URL

从2021年“罗马提议”看慢性阻塞性肺疾病急性加重定义及分级的变迁

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 13

相关文章 1

编辑推荐

Metrics

本文评价

友情链接